Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein

Virology. 2001 Apr 25;283(1):84-92. doi: 10.1006/viro.2001.0877.

Abstract

Coxsackieviruses B (CVB) (B1-B6), positive-strand RNA viruses, cause a variety of diseases. CVB4 may have a causal role in insulin-dependent diabetes mellitus. IFN-alpha inhibits CVB replication; however, the mechanism is not well known. The interferon-alpha-inducible human MxA protein exerts an antiviral activity against negative-strand RNA viruses and against Semliki Forest virus, a positive-strand RNA virus. To test the antiviral spectrum of MxA against CVB4, we took advantage of stably transfected Vero cells expressing MxA (Vero/MxA) in 98% of cells. Compared with control cells, in Vero/MxA cells, CVB4 yields were dramatically reduced and expression of the VP1 CVB protein analyzed by immunofluorescence was highly restricted. Furthermore, the accumulation of positive- and negative-strand CVB4 RNA was prevented as shown by in situ hybridization and RT-PCR. These results indicate that the antiviral activity of MxA extends to CVB4 and that its replication cycle is inhibited at an early step in Vero/MxA cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / genetics
  • Antiviral Agents / metabolism
  • Antiviral Agents / pharmacology*
  • Capsid / metabolism
  • Chlorocebus aethiops
  • Coxsackievirus Infections / virology*
  • Enterovirus B, Human / physiology*
  • Fluorescent Antibody Technique
  • GTP-Binding Proteins*
  • In Situ Hybridization
  • Myxovirus Resistance Proteins
  • Proteins / genetics
  • Proteins / metabolism
  • Proteins / physiology*
  • RNA, Viral / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection
  • Vero Cells
  • Virus Replication*

Substances

  • Antiviral Agents
  • MX1 protein, human
  • Myxovirus Resistance Proteins
  • Proteins
  • RNA, Viral
  • GTP-Binding Proteins